High materiality7/10
ASND Ascendis Pharma price target raised to $275 from $256 at Morgan Stanley
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises ASND target to $275; current price $253.6; priceChangeSinceSignal +0.87.
- Morgan Stanley raises ASND target to $275.
Key facts
- 01
Target: $275
- 02
Posted price: $253.6
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.